Precision BioSciences, Inc. rose 10.0% on Wednesday, October 28, 2026, on 189,300 shares. No headline about DTIL came out that day or the day before in the news feeds we follow, so the move may come from news we don't track, the sector or trading alone.
Precision BioSciences, Inc. (DTIL:NASDAQ) closed at $7.08 on November 3, 2026, up 1.87% on the day. The stock trades 26.4% below its 52-week high of $9.62 and 100.6% above its 52-week low of $3.53. Over the past year, it lost 5.6%. Precision BioSciences, Inc. is part of the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)).
In 252 trading sessions since October 31, 2025, DTIL closed higher on 122 days (48%). Its best day was March 10, 2026 (+13.59%) and its worst was November 17, 2025 (-12.59%). The stock moved 10% or more in a single session 12 times. It opened at least 5% above the previous day's high 1 time.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The company's segments include Therapeutics and Food.
Find more stocks like DTIL with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.